维拉佐酮(美国贸易名称Viibryd)是由默克公司开发和临床数据授权的血清素的抗抑郁药。维拉佐酮于2011由FDA批准用于美国治疗重度抑郁症。其作用机制被认为是一个结合SSRI活性(塞尔特5ht1ar抑制)和部分激动剂,如结构相关的抗焦虑药丁螺环酮。

清空选项
4635-59-0 4-Chlorobutyryl chloride
BD963114635-59-098%
¥320.00500g常备现货
143612-79-7 3-(4-Chlorobutyl)-1H-indole-5-carbonitrile
BD227883143612-79-797%
¥972.0025g常备现货
183288-46-2 5-(Piperazin-1-yl)benzofuran-2-carboxamide
BD227885183288-46-297%
¥868.0025g常备现货
10075-50-0 5-Bromoindole
BD2710210075-50-097%
¥137.00100g常备现货
174775-48-5 Ethyl 5-aminobenzofuran-2-carboxylate
BD129055174775-48-595%
¥852.0025g常备现货
97-51-8 2-Hydroxy-5-nitrobenzaldehyde
BD2329197-51-898%
¥725.00500g常备现货
35351-21-4 5-Bromobenzofuran-2-carboxamide
BD23422135351-21-498%
¥1103.005g常备现货
183288-43-9 tert-Butyl 4-(2-(ethoxycarbonyl)benzofuran-5-yl)piperazine-1-carboxylate
BD236569183288-43-995%
¥418.0025g常备现货
56-12-2 4-Aminobutyric acid
BD2147856-12-298%
¥61.00100g常备现货
334-22-5 Bis(2-chloroethyl)amine
BD145482334-22-598%
¥920.005g常备现货
69604-00-8 Ethyl 5-nitrobenzofuran-2-carboxylate
BD2222469604-00-897%
¥79.005g常备现货
2969-81-5 Ethyl 4-bromobutyrate
BD200442969-81-598%
¥192.00500g常备现货
683-57-8 2-Bromoacetamide
BD72100683-57-896%
¥55.0010g常备现货
10242-12-3 5-Nitrobenzofuran-2-carboxylic acid
BD720710242-12-398%
¥2351.0025g常备现货
15861-24-2 Indole-5-carbonitrile
BD730915861-24-297%
¥156.0025g常备现货
1398358-69-4 3-(4-Chlorobutyl)-1-tosyl-1H-indole-5-carbonitrile
BD3295861398358-69-495+%
¥4494.005g
163521-19-5 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxylic acid
BD233140163521-19-598%
¥7590.001g
183288-44-0 tert-Butyl 4-(2-carbamoylbenzofuran-5-yl)piperazine-1-carboxylate
BD233143183288-44-098%
¥12610.001g
163521-20-8 Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate
BD236567163521-20-898%
¥462.001g
294174-66-6 Ethyl 5-(bis(2-chloroethyl)amino)benzofuran-2-carboxylate
BD00813721294174-66-697%
¥1953.001g
1